Allicin treatment at higher concentrations of 50 ng/mL and 100 ng/mL significantly reduced expression of cancer stem cell surface markers CD44 and CD133 measured as median fluorescence intensity on a flow cytometer (Figure 5). This evidence concerns the gene PROM1 and cancer.